Journal article

Dose calculation of anticancer drugs

Gao B, Klumpen H, Gurney H ...see all

Expert opinion on drug metabolism & toxicology, vol. 4, issue 10 (2008) pp. 1307-1319

  • 1


    Mendeley users who have this article in their library.
  • N/A


    Citations of this article.
Sign in to save reference


Anticancer drugs are characterized by a narrow therapeutic window and significant inter-patient variability in therapeutic and toxic effects. Current body surface area (BSA)-based dosing fails to standardize systemic anticancer drug exposure and other alternative dosing strategies also have their limitations. Just as important as the initial dose selection is the subsequent dose revision to ensure the dose is correct.

Author-supplied keywords

  • 10
  • 1307-1319
  • 2008
  • 4
  • Antineoplastic Agents
  • Antineoplastic Agents: administration & dosage
  • Antineoplastic Agents: adverse effects
  • Antineoplastic Agents: pharmacokinetics
  • Dose-Response Relationship
  • Drug
  • Drug Monitoring
  • Genotype
  • Humans
  • Neoplasms
  • Neoplasms: drug therapy
  • Phenotype
  • anticancer drugs
  • body surface area
  • dose calculation
  • dose cluster
  • drug metab
  • expert opin
  • inter-individual
  • pharmacokinetics
  • structured dose revision
  • toxicity-adjusted dosing
  • toxicol
  • variability

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in

Find this document


  • Bo Gao

  • Heinz-Josef HJ Klumpen

  • Howard Gurney

Cite this document

Choose a citation style from the tabs below

Save time finding and organizing research with Mendeley

Sign up for free